SALE
市場調查報告書

醣生物學的全球市場:至2025年的預測與市場機會

Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934749
出版日期 內容資訊 英文 116 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

醣生物學的全球市場:至2025年的預測與市場機會 Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 116 Pages
簡介

全球醣生物學市場,預計在預測期間內將以驚人的速度成長。全球醣生物學市場,是受到癌症、糖尿病、腎臟疾病等慢性疾病的盛行率增加所帶動,也提高個人化醫療的需求。據此,全球的藥物研發流程增加,預計給予在預測期間內的市場成長正面影響。

本報告提供全球醣生物學各市場市場區隔和各地區調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球醣生物學市場的影響

第4章 摘要整理

第5章 客戶的迴響

  • 品牌認知度
  • 產品認識
  • 顧客滿意度分析
  • 未滿足需求和課題

第6章 全球醣生物學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型(糖苷酶和神經氨酸酶,糖基轉移酶和唾液酸轉移酶,碳水化合物激酶,碳水化合物磺基轉移酶,蛋白質磺基轉移酶,其他)
    • 套件的各類型(聚醣釋放套組,聚醣標記套組,聚醣純化套組,其他)
    • 各用途(藥物研發,疾病診斷,病毒學,細胞生物學,腫瘤學,其他)
    • 各終端用戶(調查機關,診斷中心,醫院,臨床研究所,製藥、生物科技企業,其他)
    • 各公司(2019年)
    • 各地區
  • 產品市場地圖

第7章 亞太地區的醣生物學的市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型
    • 套件的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第8章 歐洲的醣生物學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型
    • 套件的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章 北美的醣生物學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型
    • 套件的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美的醣生物學的市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型
    • 套件的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東、非洲的醣生物學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 酵素的各類型
    • 套件的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 中東、非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R&D Systems, Inc.
  • Bio-Techne
  • Danaher Corporation
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • ProZyme

第15章 策略性推薦事項

第16章 免責聲明

目錄
Product Code: 4635

Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years.

The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on type of enzyme, the market can be categorized into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is expected to dominate the market during the forecast period. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the global glycobiology market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global glycobiology market from 2015 to 2018.
  • To estimate and forecast the market size of global glycobiology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global glycobiology market based on type of enzyme, type of kit, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global glycobiology market.
  • To identify drivers and challenges for global glycobiology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global glycobiology market.
  • To identify and analyze the profile of leading players operating in global glycobiology market.
  • To identify key sustainable strategies adopted by market players in global glycobiology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global glycobiology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global glycobiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Glycobiology Market, By Type of Enzyme:

Glycosidases & Neuramidases

Glycosyltransferases & Sialytransferases

Carbohydrate Kinases

Carbohydrate Sulfotransferases

Protein Sulfotransferases

Others

  • Global Glycobiology Market, By Type of Kit:

Glycan Releasing Kit

Glycan Labelling Kit

Glycan Purification Kit

Others

  • Global Glycobiology Market, By Application:

Drug Discovery

Disease Diagnostics

Virology

Cell Biology

Oncology

Others

  • Global Glycobiology Market, By End User:

Research Institutes

Diagnostic Centers

Hospitals

Clinical Laboratories

Pharmaceutical & Biotechnology Companies

Others

  • Global Glycobiology Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global glycobiology market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global Glycobiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
    • 6.2.2. By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
    • 6.2.3. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
    • 6.2.4. By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Glycobiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Enzyme
    • 7.2.2. By Type of Kit
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Glycobiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Enzyme
        • 7.3.1.2.2. By Type of Kit
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. India Glycobiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Enzyme
        • 7.3.2.2.2. By Type of Kit
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Glycobiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Enzyme
        • 7.3.3.2.2. By Type of Kit
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Glycobiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Enzyme
        • 7.3.4.2.2. By Type of Kit
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Glycobiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Enzyme
        • 7.3.5.2.2. By Type of Kit
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Europe Glycobiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Enzyme
    • 8.2.2. By Type of Kit
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Glycobiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Enzyme
        • 8.3.1.2.2. By Type of Kit
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Glycobiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Enzyme
        • 8.3.2.2.2. By Type of Kit
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Glycobiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Enzyme
        • 8.3.3.2.2. By Type of Kit
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Glycobiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Enzyme
        • 8.3.4.2.2. By Type of Kit
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Glycobiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Enzyme
        • 8.3.5.2.2. By Type of Kit
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. North America Glycobiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Enzyme
    • 9.2.2. By Type of Kit
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Glycobiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Enzyme
        • 9.3.1.2.2. By Type of Kit
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Glycobiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Enzyme
        • 9.3.2.2.2. By Type of Kit
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Glycobiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Enzyme
        • 9.3.3.2.2. By Type of Kit
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Glycobiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Enzyme
    • 10.2.2. By Type of Kit
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Glycobiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Enzyme
        • 10.3.1.2.2. By Type of Kit
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Glycobiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Enzyme
        • 10.3.2.2.2. By Type of Kit
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Glycobiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Enzyme
        • 10.3.3.2.2. By Type of Kit
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Glycobiology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Enzyme
    • 11.2.2. By Type of Kit
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Glycobiology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type of Enzyme
        • 11.3.1.2.2. By Type of Kit
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Glycobiology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type of Enzyme
        • 11.3.2.2.2. By Type of Kit
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Glycobiology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type of Enzyme
        • 11.3.3.2.2. By Type of Kit
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Kuwait Glycobiology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type of Enzyme
        • 11.3.4.2.2. By Type of Kit
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co., Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Thermo Fisher Scientific
  • 14.4. New England Biolabs, Inc.
  • 14.5. Shimadzu Corporation
  • 14.6. Takara Bio Inc.
  • 14.7. Waters Corporation
  • 14.8. Asparia Glycomics S.L.
  • 14.9. Bruker Corporation
  • 14.10. RayBiotech, Inc.
  • 14.11. Z Biotech, LLC.
  • 14.12. Chemily Glycoscience
  • 14.13. Dextra Laboratories Ltd.
  • 14.14. Lectenz Bio
  • 14.15. Ludger Ltd
  • 14.16. R&D Systems, Inc.
  • 14.17. Bio-Techne
  • 14.18. Danaher Corporation
  • 14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • 14.20. ProZyme

15. Strategic Recommendations

16. About Us & Disclaimer